Risk factors for coronary heart disease in 1002 hyperlipidemic patients;Czynniki ryzyka choroby niedokrwiennej serca u 1002 pacjentów z hiperlipidemia

Polskie Archiwum Medycyny Wewnetrznej

Volumn 97, Issue 5, 1997, Pages 442-449

  Kłosiewicz Latoszek, Longina ^a   Pachocka, Lucyna ^a   Górska, Krystyna ^a   Grzybowska, Barbara ^a   Ostasz, Barbara ^a   Paluszkiewicz, Janina ^a   Szonert, Julita ^a   Targosz, Urszula ^a   Stolarska, Irena ^a   Nowicka, Grazyna ^b  

^a Instytutu Zywno ci i Zywienia   (Poland)

^b Oddzia u Klinicznego Zywienia i Chirurgii   (Poland)

Author keywords

Apolipoprotein B; Diabetes mellitus; Familial history; Hyperlipidemia; Hypertension; Lipoprotein (a); Myocardial infarction; Obesity; Smoking; Uric acid

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; OBESITY; RISK FACTOR; SMOKING;

ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; RISK FACTORS; SMOKING;

EID: 0031138418     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pyorala K., De Becker L., Poole-Wilson P., Wood D.: Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension Eur. Heart J., 1994, 15, 1300.
2. Prevention of coronary heart disease: scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr. Metab. Cardiovasc. Dis., 1992, 2, 113.
3. National Cholesterol Education Program, Second Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood cholesterol in Adults (Adult Treatment Panel II) Circulation, 1994, 89, 1329.
4. Thelle D.S : The relative importance of blood lipid and other atherosclerosis risk factors. Eur. Heart J., 1992, 13 (suppl. B) 29.
5. Assmann G.: Results and conclusions of the prospective cardiovascular Munster (PROCAM) Study in: Lipid Metabolism Disorders and Coronary Heart Disease. MMV Medizin Verlag GmbH Munchen, Munich, 1993, 19.
6. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major cooronary events: final report of the Pooling Project. J. Chronic Dis , 1978, 31, 201.
7. Neaton J.D., Wentworth D.: Serum cholesterol blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differens by age for 316099 white men. Arch. Intern. Med., 1992, 152, 56.
8. Califf R.M., Armstrong R.W., Carver J.R. i wsp.: Task force 5. Stratification of patients in to high, medium and low risk subgroups for purposes of risk factor management. JACC, 1996, 27, 5, 1007.
9. Heitzer T., Yla-Herttuala S., Luoma J. i wsp.: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation, 1996, 93, 1346.
10. Castelli W P.: Lipids, risk factors and ischaemic heart disease. Atherosclerosis, 1996, 124 (suppl) s1.
11. Labat J.B., Bergmann S.D., Zavoral J.H.: Women and cardiovascular disease: factors and challenges. Cardiovasc. Risk Factors, 1994, 4, 1, 51.
12. Stevenson J.C., Crook D., Godsland I.F.: Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis, 1993, 98, 83.
13. Davtgnon J., Cohn J.S.: Triglycerides: a risk factors for coronary heart disease. Atherosclerosis, 1996, 124 (suppl.) s57.
14. Cremer P., Nagel D., Labrot B. i wsp.: Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrynogen, LDL cholesterol and other risk factors: results from the prospective Gotlingen Risk Incidence and Prevalance Study (CRIPS). Eur. J. Clin. Invest., 1994, 24, 444.
15. Baillenl S., Condere R., Rossignol C. i wsp.: Lipoprotein (a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis. Clin. Chem. 1995, 41, 2, 241.
16. Klosiewicz-Latoszek L., Nowicka G.: Rodzinna hiperlipidemia. Ocena poziomu lipoprotein u rodziców i dzieci. Wiad. Lek., 1994, 47, 11/12, 401.
17. Freedman D.S., Williams D.F., Gunter E.W., Byers T.: Relation of serum uric acid to mortality and ischemic heart disease. Am. J. Epid., 1995, 141, 637.
18. Sniderman A., Wolfson C., Teng B., Franklin F.A., Bechorisk P.S., Kwieterovich P.O.Jr.: Association hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann. Intern. Med., 1982, 97, 833-839.
19. Nowicka G., Klosiewicz-Latoszek L., Szostak W.B.: Apolipoprotein B (apoB) in survivors after myocardial infarction. Żywienie Czlowieka i Metabolizm, 1995, 12, 132.
20. Klosiewicz-Latoszek L., Nowicka G.: Apolipoproteiny cz. II. Rola w praktyce klinicznej. Czynniki Ryzyka. 1994/1995, 4(6/7), 26.